Previous data have shown that anti-CD163-dexa therapy strongly reduces the acute pro-inflammatory macrophage cytokine storm (TNF-α in particular) induced by LPS27 that is suggested to play role in NASH development.47 The gene discussed is CD163; the disease is metabolic dysfunction-associated steatohepatitis.